| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 38.45B | 34.48B | 36.35B | 3.43B | 35.69B |
| Gross Profit | 5.32B | 4.84B | 4.31B | 4.07B | 14.71B |
| EBITDA | 5.32B | 5.00B | 4.48B | 4.60B | 5.86B |
| Net Income | 3.75B | 3.17B | 3.34B | 3.02B | 4.37B |
Balance Sheet | |||||
| Total Assets | 398.45B | 370.72B | 333.24B | 330.91B | 345.37B |
| Cash, Cash Equivalents and Short-Term Investments | 29.46B | 27.72B | 27.49B | 11.22B | 12.28B |
| Total Debt | 18.79B | 15.02B | 13.28B | 13.39B | 10.21B |
| Total Liabilities | 372.96B | 344.59B | 309.04B | 301.53B | 317.30B |
| Stockholders Equity | 25.23B | 26.05B | 23.58B | 27.45B | 26.31B |
Cash Flow | |||||
| Free Cash Flow | 2.65B | 2.39B | 5.44B | 8.00B | -1.94B |
| Operating Cash Flow | 2.80B | 2.53B | 5.61B | 4.31B | -1.86B |
| Investing Cash Flow | -320.00M | -337.00M | -559.00M | -2.86B | -803.00M |
| Financing Cash Flow | -2.64B | -3.88B | -3.09B | -71.00M | -260.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | C$49.02B | 12.88 | 14.68% | 4.11% | -19.88% | -13.92% | |
72 Outperform | C$81.44B | 14.68 | 11.34% | 3.49% | 5.46% | 10.52% | |
72 Outperform | C$14.18B | 15.09 | 13.62% | 2.11% | -25.13% | 16.40% | |
70 Outperform | C$43.23B | 17.80 | 12.83% | 3.28% | -9.03% | 44.14% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | C$59.66B | 14.06 | 13.98% | 3.62% | -20.64% | 14.88% |